Quanthealth

Simulates thousands of patient scenarios and predicts clinical trial outcomes before launching real-world studies. Uses AI models trained on historical patient data to forecast efficacy, safety, and statistical success rates across different patient populations.

Evaluates the risk of clinical trial failure by analyzing trial design, patient cohort characteristics, and historical success rates for similar compounds. Identifies high-risk design elements before expensive enrollment begins.

Recommends adaptive trial design strategies such as interim analyses, sample size re-estimation, and population enrichment based on simulated trial data. Identifies opportunities to modify trials mid-course for improved efficiency.

Analyzes competitive drugs and trial designs in the same indication to inform positioning strategy and identify differentiation opportunities. Compares efficacy, safety, and trial design approaches of competing compounds.

Analyzes patient populations and recommends optimal cohort definitions and stratification strategies to maximize trial statistical power and success likelihood. Identifies which patient subgroups are most likely to show drug efficacy.

Projects compressed drug development timelines by identifying opportunities to run trials in parallel, reduce enrollment periods, or combine phases. Estimates time savings compared to traditional sequential trial approaches.

Predicts drug efficacy outcomes across different patient populations, disease severities, and demographic groups using AI models trained on historical trial data. Generates population-specific efficacy forecasts.

Analyzes and predicts safety risks and adverse event profiles for drug candidates across patient populations. Identifies which patient subgroups are at highest risk for specific adverse events.

Calculates optimal sample sizes and statistical power requirements for trial designs based on simulated outcomes and historical data. Recommends sample size adjustments to maximize power while minimizing enrollment burden.

Provides recommendations for optimal regulatory pathways and trial designs based on drug characteristics, indication, and historical regulatory precedent. Suggests strategies to accelerate FDA or other regulatory approvals.

Calculates projected costs and financial benefits of different trial designs, including development costs, enrollment expenses, and potential cost savings from failure prevention. Compares financial outcomes across design alternatives.

Integrates and analyzes historical clinical trial data from internal databases, published literature, and external sources to build training datasets for simulations. Performs data quality assessment and identifies gaps in historical information.